Highly potent antisense oligonucleotides (ASOs) targeting the SARS-CoV-2 RNA genome
Vita Dauksaite, Ali Taş, Falk Wachowius, A. Spruit, Martijn J. van Hemert, Eric J. Snijder, Eric P. van der Veer, Anton Jan van Zonneveld
ASOs (LNA gapmers) targeting the SARS-CoV-2 RNA genome effectively reduce viral RNA load by up to 96% in vitro.
bioRxiv · Nov 28, 2022 · PreprintMolecular Biology